Waters Parkerson & Co.在第二季度收购了Vertex Pharmaceuticals的462股股票，加入了其他对冲基金增加他们的股份。 Waters Parkerson & Co. acquired 462 shares of Vertex Pharmaceuticals in Q2, joining other hedge funds increasing their stakes.

沃特斯帕克森公司在第二季度收购了价值约217,000美元的Vertex Pharmaceuticals （纳斯达克股票代码：VRTX）的462股股票，加入了多个增加股份的对冲基金的行列。 Waters Parkerson & Co. LLC acquired 462 shares of Vertex Pharmaceuticals (NASDAQ:VRTX) worth about $217,000 in Q2, joining multiple hedge funds that have increased their stakes. 机构投资者拥有公司90.96%的股份。 Institutional investors own 90.96% of the company. 最近，内部人士出售股票，分析师给出了不同的评级，一致意见为“持有”，目标价为 486.36 美元。 Recently, insiders sold shares, and analysts provided varied ratings, with a consensus "Hold" and a price target of $486.36. VRTX股票开放额为464.92美元,市场上限为119.97亿美元,52周范围为341.85至510.64美元。 VRTX shares opened at $464.92, with a market cap of $119.97 billion and a 52-week range of $341.85 to $510.64.